Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals.
Clinical Benefit
| Insufficient |
The actual benefit of LERCAPRESS 10 mg/10 mg is insufficient in view of the available clinical data: this data is insufficient to assess its value for the management of hypertensive patients. |
| Substantial |
|
Clinical Added Value
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
gBkdUaPMbRgBN2QL
